乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) […]
了解更多乔治临床( George Clinical ) welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke resea […]
了解更多乔治临床( George Clinical ) welcomes the recent announcement by our partner organization, West Cancer Center of their intention to join OneOncology in January 2019. The announcement sees a departu […]
了解更多SYDNEY, January 22, 2019 – 乔治临床( George Clinical ), headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief […]
了解更多乔治临床( George Clinical ), a leading clinical research organization (CRO) in the Asia-Pacific region, has gained recognition of the organization’s strong support of the Mandatory Provident Fund […]
了解更多
In another encouraging step towards making China a leading destination for clinical drug trials, some critical developments were announced at The Executive Meeting of the State Council on the […]
了解更多
George Clinical, a leading full-service CRO in the US and Asia-Pacific region, is pleased to announce that Matthew Reabold, Sr. has been promoted to the Head of Business Development, USA. 乔治临床 […]
了解更多
Sydney, Australia (May 2, 2017) – 乔治临床( George Clinical ), a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analy […]
了解更多
乔治临床( George Clinical ) is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significan […]
了解更多
乔治临床( George Clinical ) is pleased to announce the continued expansion of their Business Development operations in the US, with the recent appointments of Mindy Farr as Senior Business Develop […]
了解更多
